Liang-Wang Syndrome
Genetics
Typically caused by de novo heterozygous loss-of-function variants in KCNMA1, which encodes the BK calcium- and voltage-activated potassium channel. The recurrent p.Gly375Arg variant causes near-complete loss of BK current.
Molecular Mechanism
Aberrant function of BK-channel function disrupts membrane repolarization and calcium-coupled excitability in neurons, smooth muscle and endocrine cells. This mechanism must be distinguished from other KCNMA1 channelopathies caused by gain-of-function variants.
Therapy
Management is symptomatic, including treatment of epilepsy, movement disorder, feeding, motor impairment and organ-specific complications. No validated variant-directed therapy is available, and channel-modulating drugs require functional stratification because KCNMA1 variants can have opposite effects.
CCP Activity
CCP is developing a KCNMA1 p.Gly375Arg model. Characterization is designed to link channel function alteration to neurobehavioral, EEG, motor, metabolic and visceral phenotypes and to establish endpoints for mechanism-based rescue studies.
Mouse Models Mouse Models & Gene Cards
| Mouse Models | Gene Cards |
| TBD | TBD |